Massive Bioinformatics provides bioinformatics and biotechnology solutions aimed at enhancing the quality of life through innovative products and services, self-described as a team of dedicated scientists and software engineers.

Massive Bioinformatics

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering to allow expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic manipulation of cells is performed outside the body prior to transplantation. The company's lead product candidate is JSP191, which is in clinical development as a conditioning antibody that clears hematopoietic stem cells from bone marrow in patients prior to undergoing allogeneic stem cell therapy or stem cell gene therapy. It is also developing engineered hematopoietic stem cells product candidates to overcome key limitations of allogeneic and autologous gene-edited stem cell grafts. The company is based in Redwood City, California.

Susan Prohaska

Judith Shizuru M.D.

Jasper Therapeutics, Inc.

21stBio specializes in industrial biotechnology, providing development and scaling solutions through experience and a proven technology platform. Self-described as a partner in bridging innovation to viable business.

21stBio

Bento Lab is a portable lab that offers a thermocycler, 13k rpm centrifuge, and gel electrophoresis for molecular biology applications. It focuses on enabling on-site DNA analysis and testing.

Metric
Company Name	Massive Bioinformatics	Jasper Therapeutics, Inc.	21	Bento Lab
Symbol		JSPR
MSH ID	COM:MASSIVEBIOINFORMATICS	COM:JASPERTHERAPEUTICS	BIO:21ST	BIO:BENTO
Market	PRIVATE	STOCKS	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare	Technology	Healthcare & Health Services
Industry	Biotechnology	Biotechnology	Biotechnology	Biotechnology
Country	TR	US	DK	UK
Stage
Employee Count		45
Website	massivebioinformatics.com	jaspertherapeutics.com	21st.bio	bento.bio
LinkedIn		jaspertherapeutics
Founders

Metric
Market Cap		299.75M
Enterprise Value
Monthly Web Traffic	833
Web Traffic Growth	0.18
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:MASSIVEBIOINFORMATICS

Massive Bioinformatics

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue